ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: Zynerba Pharmaceuticals Inc (ZYNE) Report Updated: Sep 16, 2017 | Print This Page

Get more stock ratings by Louis Navellier

Zynerba Pharmaceuticals Inc (ZYNE)

Rating: Sell Volatility: Aggressive
Total Grade: D Industry: Pharmaceuticals
Competitors: SNY,CORT,ASMB,MYOK

Stock Analysis

Rating: Monthly View

A
B
C
D
F
September October November December January February March April May June July August

Rating: Weekly View

This Week: D down downgrade
Last Week: C same no change
Two Weeks Ago: C up no change
service keys

Zynerba Pharmaceuticals Inc© quotemedia

Company Profile